Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deferasirox impact on immune function in iron overload
NCT01273766Phase 2Completed
- Sponsor
- Wake Forest University Health Sciences
- Start
- Jan 2011
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of deferasirox in iron overload, sponsored by Wake Forest University Health Sciences. Started Jan 2011; status: completed.
02
Drugs
deferasirox
03
Conditions
iron overload
Beyond the preview
Go deeper on NCT01273766.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01273766.